scholarly journals Systemic Lupus Erythematosus Progression and role of Genetic Variation in IL-22 and FOXP3 gene in population of Lahore, Pakistan

Author(s):  
Nageen Hussain ◽  
Syeda Aneela ◽  
Noor Aqsa ◽  
Talib Hussain ◽  
Muhammad Ahmad Saeed

Abstract Systemic Lupus Erythematosus (SLE) is one of autoimmune disorders. It is thought that the deregulation in the inflammatory markers is due to problem in Forkhead box family member (FOXP3) which is involved in tolerance mechanism. One cannot ignore the role of cytokine-mediated signaling pathways like IL-22. This study was done in the Lahore. Pakistan. The main objective of the study was to monitor the patients of SLE. The purpose was to check the alliance of FoxP3 and IL-22 gene polymorphism. Sixty samples (n = 60) were collected from different hospitals of Lahore. DNA was extracted from EDTA anticoagulated blood of SLE patients. After DNA extraction, IL-22 and FoxP3 genes were polymerized through PCR and further sequenced through Sanger Sequencing method. The FOXP3 exon 2 and three SNPs in IL-2 i.e. rs2227491, rs2227485 and rs2227513 which were already identified were confirmed by Chromas 2.6. The mutations were checked with the help of Nucleotide Blast. Our observation showed that there are nine mutations in studied genotyped samples. The frequency of mutation was 27.27%. Allele T in rs2227485 and, allele C in rs2227513 and rs2227491 was identified in the study predominantly. These 9 mutations were found in case of IL-22 gene. No mutation was observed in Exon 2 of FOXP3 gene in SLE patients. It is concluded that that there may be any association between IL-22 gene polymorphism and SLE but FOXP3 gene was not tangled in the progression of SLE in Lahore population.

2020 ◽  
Vol 23 (13) ◽  
Author(s):  
Ikram khazal Qasim Al- hasso ◽  
Aida Rashid Al- Derzi ◽  
Ahmed Abdul-hassan Abbas ◽  
Faiq I. Gorial ◽  
Ahmed Sameer Alnuimi

2020 ◽  
Vol 8 ◽  
pp. 2050313X2091002 ◽  
Author(s):  
Umut Selamet ◽  
Ramy M Hanna ◽  
Anthony Sisk ◽  
Lama Abdelnour ◽  
Lena Ghobry ◽  
...  

Drug-induced lupus erythematosus has features distinct from primary systemic lupus erythematosus. It can occur with a wide variety of agents that result in the generation of anti-histone or other types of antibodies. Systemic manifestations of drug-induced systemic lupus erythematosus may include renal dysfunction due to circulating immune complexes or due to other immune reactions to the culprit medication(s). Acute interstitial nephritis occurs due to DNA–drug or protein–drug complexes that trigger an allergic immune response. We report a patient who developed acute kidney injury, rash, and drug-induced systemic lupus diagnosed by serologies after starting chlorthalidone and amiodarone. A renal biopsy showed acute interstitial nephritis and not lupus-induced glomerulonephritis. It is important to note that systemic lupus erythematosus and acute interstitial nephritis can occur together, and this report highlights the role of the kidney biopsy in ascertaining the pathological diagnosis and outlining therapy in drug-induced lupus erythematosus.


2010 ◽  
Vol 75 (6) ◽  
pp. 696-700 ◽  
Author(s):  
P. Piotrowski ◽  
M. Lianeri ◽  
M. Wudarski ◽  
J. K. Łącki ◽  
P. P. Jagodziński

2016 ◽  
Vol 113 (38) ◽  
pp. 10637-10642 ◽  
Author(s):  
Elaine V. Lourenço ◽  
Aijing Liu ◽  
Giuseppe Matarese ◽  
Antonio La Cava

Leptin is an adipocytokine that plays a key role in the modulation of immune responses and the development and maintenance of inflammation. Circulating levels of leptin are elevated in systemic lupus erythematosus (SLE) patients, but it is not clear whether this association can reflect a direct influence of leptin on the propathogenic events that lead to SLE. To investigate this possibility, we compared the extent of susceptibility to SLE and lupus manifestations between leptin-deficient (ob/ob) and H2-matched leptin-sufficient (wild-type, WT) mice that had been treated with the lupus-inducing agent pristane. Leptin deficiency protected ob/ob mice from the development of autoantibodies and renal disease and increased the frequency of immunoregulatory T cells (Tregs) compared with leptin-sufficient WT mice. The role of leptin in the development of SLE was confirmed in the New Zealand Black (NZB) × New Zealand White (NZW)F1 (NZB/W) mouse model of spontaneous SLE, where elevated leptin levels correlated with disease manifestations and the administration of leptin accelerated development of autoantibodies and renal disease. Conversely, leptin antagonism delayed disease progression and increased survival of severely nephritic NZB/W mice. At the cellular level, leptin promoted effector T-cell responses and facilitated the presentation of self-antigens to T cells, whereas it inhibited the activity of regulatory CD4 T cells. The understanding of the role of leptin in modulating autoimmune responses in SLE can open possibilities of leptin-targeted therapeutic intervention in the disease.


2008 ◽  
Vol 4 (1) ◽  
pp. 33-42
Author(s):  
Kerstin Sarter ◽  
Connie Schulze ◽  
Reinhard E Voll ◽  
Martin Herrmann

Author(s):  
A. Giancotti ◽  
A. Spagnuolo ◽  
F. Bisogni ◽  
V. D’Ambrosio ◽  
G. Pasquali ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document